Home Featured Post NICE in the UK issues recommendation for Sleepio app, the digital cognitive behavioural therapy for insomnia by Big Health

NICE in the UK issues recommendation for Sleepio app, the digital cognitive behavioural therapy for insomnia by Big Health

by admin
0 comment


Sleepio becomes first dig­i­tal ther­a­peu­tic to receive NICE guid­ance (Mobi­Health­News):

The Nation­al Insti­tute for Health and Care Excel­lence (NICE) has rec­om­mend­ed the Sleepio app as an effec­tive alter­na­tive to sleep­ing pills.

In its guid­ance, NICE states the app, cre­at­ed by dig­i­tal ther­a­peu­tics (DTx) firm Big Health, is a safe and effec­tive treat­ment for peo­ple suf­fer­ing from insomnia.

… The Sleepio app uses an arti­fi­cial intel­li­gence (AI) algo­rithm to pro­vide peo­ple with tai­lored dig­i­tal cog­ni­tive behav­iour­al ther­a­py for insom­nia (CBT‑I).

Jeanette Kusel, act­ing direc­tor for med tech and dig­i­tal, NICE, said: “Our rig­or­ous, trans­par­ent, and evi­dence-based analy­sis has found that Sleepio is cost sav­ing for the NHS com­pared with usu­al treat­ments in pri­ma­ry care. It will also reduce peo­ple with insomnia’s reliance on depen­dence form­ing drugs such as zolpi­dem and zopiclone.

This is a good exam­ple of where a dig­i­tal health tech­nol­o­gy can help the NHS. The evi­dence has shown using Sleepio reduces the num­ber of GP appoint­ments peo­ple with insom­nia need and will also cut the num­ber of pre­scrip­tions for sleep­ing pills deliv­ered by pharmacists.”

The new guidance by NICE (May 20th, 2022):

Sleepio to treat insom­nia and insom­nia symptoms

1.1 Sleepio is rec­om­mend­ed as a cost sav­ing option for treat­ing insom­nia and insom­nia symp­toms in pri­ma­ry care for peo­ple who would oth­er­wise be offered sleep hygiene or sleep­ing pills.

1.2 For peo­ple who may be at high­er risk of oth­er sleep dis­or­der con­di­tions, such as in preg­nan­cy, or in peo­ple with comor­bidi­ties, a med­ical assess­ment should be done before refer­ral to Sleepio.

1.3 More research or data col­lec­tion is rec­om­mend­ed on Sleepio for peo­ple who are eli­gi­ble for face-to-face cog­ni­tive behav­iour­al ther­a­py for insom­nia (CBT?I) in pri­ma­ry care. This is because there is lim­it­ed clin­i­cal evi­dence to show how effec­tive Sleepio is com­pared with face-to-face CBT?I.

… At a price of £45 per per­son, Sleepio is cost sav­ing com­pared with usu­al treat­ment in pri­ma­ry care. This is based on an analy­sis of pri­ma­ry care resource use data before and after Sleepio was intro­duced in 9 GP prac­tices. Health­care costs were low­er at 1 year, most­ly because of few­er GP appoint­ments and sleep­ing pills prescribed.

News in Context:





Source link

Leave a Comment